Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

US Patent 10669337 · Granted Jun 2, 2020

Estimated economic value: $3,753,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and me2025
Proteins comprising CD3 antigen binding domains and uses thereof2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Antibodies, activatable antibodies, bispecific antibodies, and bispecific activa2025
Gene-edited natural killer cells2025
T-cells expressing anti-LIV1 chimeric antigen receptor2025
HER-2 targeted bispecific compositions and methods for making and using the same2025
Activatable anti-VEGF scFv2025
Anti-PTK7 immune cell cancer therapy2024
Protease-resistant systems for polypeptide display and methods of making and usi2024